
[ Wed, Oct 17th 2018 ]: WOPRAI
[ Wed, Oct 17th 2018 ]: WOPRAI
[ Wed, Oct 17th 2018 ]: WOPRAI
[ Wed, Oct 17th 2018 ]: WOPRAI
[ Wed, Oct 17th 2018 ]: WOPRAI
[ Wed, Oct 17th 2018 ]: WOPRAI
[ Wed, Oct 17th 2018 ]: WOPRAI
[ Wed, Oct 17th 2018 ]: WOPRAI
[ Wed, Oct 17th 2018 ]: WOPRAI
[ Wed, Oct 17th 2018 ]: WOPRAI
[ Wed, Oct 17th 2018 ]: WOPRAI
[ Wed, Oct 17th 2018 ]: WOPRAI
[ Wed, Oct 17th 2018 ]: WOPRAI
[ Wed, Oct 17th 2018 ]: WOPRAI
[ Wed, Oct 17th 2018 ]: WOPRAI
[ Wed, Oct 17th 2018 ]: WOPRAI

[ Tue, Oct 16th 2018 ]: WOPRAI
[ Tue, Oct 16th 2018 ]: WOPRAI
[ Tue, Oct 16th 2018 ]: WOPRAI
[ Tue, Oct 16th 2018 ]: WOPRAI
[ Tue, Oct 16th 2018 ]: WOPRAI
[ Tue, Oct 16th 2018 ]: WOPRAI
[ Tue, Oct 16th 2018 ]: WOPRAI
[ Tue, Oct 16th 2018 ]: WOPRAI
[ Tue, Oct 16th 2018 ]: WOPRAI
[ Tue, Oct 16th 2018 ]: WOPRAI
[ Tue, Oct 16th 2018 ]: WOPRAI
[ Tue, Oct 16th 2018 ]: WOPRAI
[ Tue, Oct 16th 2018 ]: WOPRAI
[ Tue, Oct 16th 2018 ]: WOPRAI
[ Tue, Oct 16th 2018 ]: WOPRAI
[ Tue, Oct 16th 2018 ]: WOPRAI

[ Mon, Oct 15th 2018 ]: WOPRAI
[ Mon, Oct 15th 2018 ]: WOPRAI
[ Mon, Oct 15th 2018 ]: WOPRAI
[ Mon, Oct 15th 2018 ]: WOPRAI
[ Mon, Oct 15th 2018 ]: WOPRAI
[ Mon, Oct 15th 2018 ]: WOPRAI
[ Mon, Oct 15th 2018 ]: WOPRAI
[ Mon, Oct 15th 2018 ]: WOPRAI
[ Mon, Oct 15th 2018 ]: WOPRAI
[ Mon, Oct 15th 2018 ]: WOPRAI
[ Mon, Oct 15th 2018 ]: WOPRAI
[ Mon, Oct 15th 2018 ]: WOPRAI
[ Mon, Oct 15th 2018 ]: WOPRAI
[ Mon, Oct 15th 2018 ]: WOPRAI
[ Mon, Oct 15th 2018 ]: WOPRAI
[ Mon, Oct 15th 2018 ]: WOPRAI
Do Kim Maintained (ALNY) at Buy with Decreased Target to $124 on, Oct 16th, 2018


🞛 This publication is a summary or evaluation of another publication
Do Kim of BMO Capital, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Buy with Decreased Target from $125 to $124 on, Oct 16th, 2018.
Do has made no other calls on ALNY in the last 4 months.
There are 7 other peers that have a rating on ALNY. Out of the 7 peers that are also analyzing ALNY, 1 agrees with Do's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- David Lebovitz of "Morgan Stanley" Maintained at Hold with Decreased Target to $87 on, Friday, September 28th, 2018
These are the ratings of the 6 analyists that currently disagree with Do
- Olivia Brayer of "Cantor Fitzgerald" Initiated at Buy and Held Target at $135 on, Monday, October 1st, 2018
- Paul Matteis of "Stifel" Maintained at Strong Buy with Decreased Target to $117 on, Thursday, September 13th, 2018
- Ritu Baral of "Cowen & Co." Maintained at Buy with Decreased Target to $147 on, Monday, August 13th, 2018
- Stephen Willey of "Stifel" Maintained at Strong Buy with Decreased Target to $123 on, Monday, August 13th, 2018
- Madhu Kumar of "B. Riley Securities" Maintained at Strong Buy with Increased Target to $230 on, Monday, August 13th, 2018
- Christopher Marai of "Nomura" Maintained at Sell with Decreased Target to $73 on, Monday, August 13th, 2018
Similar Stocks and Investing Publications
[ Mon, Oct 01st 2018 ]: WOPRAI
[ Fri, Sep 28th 2018 ]: WOPRAI
[ Thu, Sep 13th 2018 ]: WOPRAI
[ Thu, Jan 25th 2018 ]: WOPRAI
[ Thu, Nov 09th 2017 ]: WOPRAI
[ Thu, Nov 09th 2017 ]: WOPRAI
[ Wed, Nov 08th 2017 ]: WOPRAI
[ Wed, Nov 08th 2017 ]: WOPRAI
[ Fri, Nov 03rd 2017 ]: WOPRAI
[ Thu, Nov 02nd 2017 ]: WOPRAI
[ Mon, Oct 30th 2017 ]: WOPRAI
[ Mon, Oct 02nd 2017 ]: WOPRAI